CLSI C52

Toxicology and Drug Testing in the Medical Laboratory, 3rd Edition

This guideline provides an overview of drug testing by medical laboratories, including testing for drugs of abuse. It discusses the preexamination, examination, and postexamination considerations for specimen collection, methods of analysis, and the reporting and interpretation of results.

This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of December 2021. The document’s next scheduled review is generally five years after the reaffirmation date.

More Details

Member price:

List Price:

Add to Cart

Details

Chairholder: Patrick B. Kyle, PhD, DABCC

Date of Publication: January 15, 2017

Order Code PDF: CLSI C52Ed3E
ISBN Number: 1-56238-809-6

Order Code Print: CLSI C52Ed3
ISBN Number: 1-56238-808-8

Edition: Third

Pages: 58

CLSI C52 Additional Details

This document was formerly sold under the code T/DM8.

CLSI C52 Abstract

Clinical and Laboratory Standards Institute guideline C52— Toxicology and Drug Testing in the Medical Laboratory helps medical laboratories develop procedures for analyzing drugs of abuse and other compounds. C52 provides guidance on clinical toxicology testing from the initial consultation through final result reporting and interpretation, and includes a variety of specimen types, analytical procedures, and instrumentation.